Financials data is unavailable for this security.
View more
Year on year Zealand Pharma A/S grew revenues 229.65% from 103.99m to 342.79m while net income improved from a loss of 1.20bn to a smaller loss of 703.74m.
Gross margin | 72.06% |
---|---|
Net profit margin | -1,369.25% |
Operating margin | -1,465.34% |
Return on assets | -17.83% |
---|---|
Return on equity | -19.67% |
Return on investment | -18.63% |
More ▼
Cash flow in DKKView more
In 2023, cash reserves at Zealand Pharma A/S fell by 619.92m. Cash Flow from Financing totalled 907.01m or 264.60% of revenues. In addition the company used 425.67m for operations while cash used for investing totalled 1.09bn.
Cash flow per share | -12.13 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 125.74 |
---|---|
Tangible book value per share | 125.58 |
More ▼
Balance sheet in DKKView more
Current ratio | 35.49 |
---|---|
Quick ratio | 35.49 |
Total debt/total equity | 0.0439 |
---|---|
Total debt/total capital | 0.042 |
More ▼